Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,696 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

NCT01069835

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Barnaul, Altaiskiy Krai, Russia
  • Research Site Birobidzhan, EAO, Russia
  • Research Site Khabarovsk, Khabarovskiy Krai, Russia
  • Research Site Khanty-Mansyisk, Khanty-Mansyiskyi AO, Russia
View all 31 locations
View Trial Details
Completed

Trial of Poor Performance Status Patients (ToPPS)

NCT00892710

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic - AZ Scottsdale, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Wilshire Oncology Medical Group LaVerne, California, United States
View all 27 locations
View Trial Details
Completed

Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

NCT02175381

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Crete, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • 401 Military Hospital of Athens Athens, Greece
  • Air Forces Military Hospital of Athens Athens, Greece Athens, Greece
View Trial Details
Completed

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

NCT01598597

Conditions
Adenocarcinoma, Astrocytoma, Breast Cancer, +45 more
Locations
  • Many Locations, Alabama, United States
  • Many Locations, Alaska, United States
  • Many Locations, Arizona, United States
  • Many Locations, Arkansas, United States
View all 50 locations
View Trial Details
Completed

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

NCT00743379

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +28 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • LSU Health Sciences Center Shreveport, Louisiana, United States
View Trial Details
Completed

Lung Screening Study

NCT00006382

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

NCT00172042

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Jette, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Liège, Belgium
  • Novartis Investigative Site Beijing, China
View all 69 locations
View Trial Details

Related conditions